{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:35:19Z","timestamp":1789601719978,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"Turun Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022793","name":"Turku University Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["264817"],"award-info":[{"award-number":["264817"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["132389"],"award-info":[{"award-number":["132389"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejps.2023.106571","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T01:59:08Z","timestamp":1693274348000},"page":"106571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours"],"prefix":"10.1016","volume":"190","author":[{"given":"Nataliia","family":"Petruk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0564-7033","authenticated-orcid":false,"given":"Martine","family":"Croset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Polari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hristo","family":"Zlatev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katri","family":"Selander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka","family":"M\u00f6nkk\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Cl\u00e9zardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8752-6862","authenticated-orcid":false,"given":"Jorma","family":"M\u00e4\u00e4tt\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2023.106571_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(10)70054-1","article-title":"Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial","volume":"11","author":"Aft","year":"2010","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0003","doi-asserted-by":"crossref","DOI":"10.1080\/21541248.2015.1085485","article-title":"A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton","volume":"6","author":"Ali","year":"2015","journal-title":"Small GTPases"},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-020-02669-7","article-title":"Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC","volume":"70","author":"Bao","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"13","key":"10.1016\/j.ejps.2023.106571_bib0006","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-10-3862","article-title":"High phosphoantigen levels in bisphosphonate-treated human breast tumors promote V\u03b39V\u03b42 T-cell chemotaxis and cytotoxicity in vivo","volume":"71","author":"Benza\u00efd","year":"2011","journal-title":"Cancer Res."},{"issue":"22","key":"10.1016\/j.ejps.2023.106571_bib0007","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-12-0918","article-title":"In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger V\u03b39V\u03b42 T-cell antitumor cytotoxicity through ICAM-1 engagement","volume":"18","author":"Benza\u00efd","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"48","key":"10.1016\/j.ejps.2023.106571_bib0008","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.20539","article-title":"Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer","volume":"8","author":"Cai","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejps.2023.106571_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15081","article-title":"Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer","volume":"8","author":"Chung","year":"2017","journal-title":"Nat. Commun."},{"issue":"10001","key":"10.1016\/j.ejps.2023.106571_bib0011","first-page":"1353","article-title":"Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials","volume":"386","author":"Coleman","year":"2015","journal-title":"Lancet North Am. Ed."},{"key":"10.1016\/j.ejps.2023.106571_bib0012","doi-asserted-by":"crossref","unstructured":"Croset, M. et\u00a0al. (2018) \u2018MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes\u2019, in. doi: 10.1158\/1538-7445.am2018-486.","DOI":"10.1158\/0008-5472.CAN-17-3058"},{"issue":"5","key":"10.1016\/j.ejps.2023.106571_bib0013","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.ejps.2023.106571_bib0014","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djz215","article-title":"Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307","volume":"112","author":"Gralow","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"12","key":"10.1016\/j.ejps.2023.106571_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008482","article-title":"A transcriptome-based signature of pathological angiogenesis predicts breast cancer patient survival","volume":"15","author":"Guarischi-Sousa","year":"2019","journal-title":"PLoS Genet."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2249.2005.02665.x","article-title":"The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood \u03b3\u03b4 T cells in response to aminobisphosphonates is inhibited by statins","volume":"139","author":"Hewitt","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejps.2023.106571_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.09.023","article-title":"In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with \u03b3\u03b4 T cell immunotherapy in mice","volume":"241","author":"Hodgins","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2023.106571_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00800","article-title":"Improving the efficiency of V\u03b39V\u03b42 T-cell immunotherapy in cancer","author":"Hoeres","year":"2018","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.ejps.2023.106571_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2021.02.003","article-title":"The capacity of CD4+ V\u03b39V\u03b42 T cells to kill cancer cells correlates with co-expression of CD56","volume":"23","author":"Holmen Olofsson","year":"2021","journal-title":"Cytotherapy"},{"issue":"27","key":"10.1016\/j.ejps.2023.106571_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2009.07.010","article-title":"Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry","volume":"877","author":"Jauhiainen","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0021","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-14-0621","article-title":"Real-time intravital imaging establishes tumor-associated macrophages as the extraskeletal target of bisphosphonate action in cancer","volume":"5","author":"Junankar","year":"2015","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-018-0074-9","article-title":"Zoledronic acid exacerbates inflammation through M1 macrophage polarization","volume":"38","author":"Kaneko","year":"2018","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.ejps.2023.106571_bib0023","first-page":"54","article-title":"Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: a meta-analysis of randomised trials","author":"Kroep","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejps.2023.106571_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2019.12.001","article-title":"Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment","author":"La-Beck","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejps.2023.106571_bib0025","first-page":"645","article-title":"Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma","author":"Lisi","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0026","article-title":"Zoledronic acid blocks the interaction between breast cancer cells and regulatory T-cells","volume":"19","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejps.2023.106571_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7676","article-title":"Myeloid cell-derived inducible nitric oxide synthase suppresses M1 macrophage polarization","volume":"6","author":"Lu","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2023.106571_bib0028","doi-asserted-by":"crossref","DOI":"10.7150\/jca.44313","article-title":"Angiogenesis in breast cancer progression, diagnosis, and treatment","author":"Madu","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejps.2023.106571_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2010.09.003","article-title":"Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects","author":"Maruyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.ejps.2023.106571_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/emboj.2008.73","article-title":"NF-\u03baB dictates the degradation pathway of I\u03baB\u03b1","volume":"27","author":"Mathes","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.ejps.2023.106571_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.643771","article-title":"Macrophage biology and mechanisms of immune suppression in breast cancer","author":"Mehta","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ejps.2023.106571_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2009.08.010","article-title":"The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro","volume":"45","author":"Mitrofan","year":"2009","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.ejps.2023.106571_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/S0378-4347(99)00559-9","article-title":"Analysis of an adenine nucleotide-containing metabolite of clodronate using ion pair high-performance liquid chromatography-electrospray ionisation mass spectrometry","volume":"738","author":"M\u00f6nkk\u00f6nen","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0034","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706628","article-title":"A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates","volume":"147","author":"M\u00f6nkk\u00f6nen","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0035","doi-asserted-by":"crossref","DOI":"10.3109\/10611869409015910","article-title":"Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro","volume":"2","author":"M\u00f6nkk\u00f6nen","year":"1994","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ejps.2023.106571_bib0036","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.72430","article-title":"Bisphosphonate drugs have actions in the lung and inhibit the mevalonate pathway in alveolar macrophages","volume":"10","author":"Munoz","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.ejps.2023.106571_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.ejps.2023.106571_bib0038","doi-asserted-by":"crossref","DOI":"10.1038\/nri3073","article-title":"Protective and pathogenic functions of macrophage subsets","author":"Murray","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejps.2023.106571_bib0039","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.475","article-title":"Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions","author":"Okamoto","year":"2014","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.ejps.2023.106571_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djn240","article-title":"Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer","volume":"100","author":"Ottewell","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"11","key":"10.1016\/j.ejps.2023.106571_bib0041","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1402200","article-title":"Adoptive immunotherapy of epithelial ovarian cancer with V\u03b39V\u03b42 T cells, potentiated by liposomal alendronic acid","volume":"193","author":"Parente-Pereira","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0042","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0697-7","article-title":"Natural killer T cell activation increases iNOS+CD206- M1 macrophage and controls the growth of solid tumor","volume":"7","author":"Paul","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"7","key":"10.1016\/j.ejps.2023.106571_bib0043","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1158\/1078-0432.CCR-16-0547","article-title":"Oral bisphosphonates and improved survival of breast cancer","volume":"23","author":"Rennert","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2023.106571_bib0044","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: current status","author":"Roelofs","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2023.106571_bib0045","doi-asserted-by":"crossref","DOI":"10.1007\/s13402-019-00453-z","article-title":"Tumor-associated macrophages: role in cancer development and therapeutic implications","author":"Salmaninejad","year":"2019","journal-title":"Cell. Oncol."},{"issue":"7","key":"10.1016\/j.ejps.2023.106571_bib0046","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.ejps.2023.106571_bib0047","doi-asserted-by":"crossref","DOI":"10.1007\/s12149-018-1278-4","article-title":"Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial","volume":"32","author":"Seider","year":"2018","journal-title":"Ann. Nucl. Med."},{"issue":"11","key":"10.1016\/j.ejps.2023.106571_bib0048","doi-asserted-by":"crossref","DOI":"10.1158\/1541-7786.MCR-19-0756","article-title":"Targeting the mevalonate pathway to overcome acquired anti-HER2 treatment resistance in breast cancer","volume":"17","author":"Sethunath","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"3","key":"10.1016\/j.ejps.2023.106571_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2013.02.003","article-title":"Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity","volume":"167","author":"Shmeeda","year":"2013","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0050","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-015-1005-7","article-title":"Liposome encapsulated zoledronate favours M1-like behaviour in murine macrophages cultured with soluble factors from breast cancer cells","volume":"15","author":"Sousa","year":"2015","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0051","doi-asserted-by":"crossref","DOI":"10.1007\/s11864-018-0535-z","article-title":"Adjuvant bisphosphonate therapy in postmenopausal breast cancer","volume":"19","author":"Strobl","year":"2018","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ejps.2023.106571_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2017.10.006","article-title":"Tumor angiogenesis and bone metastasis - correlation in invasive breast carcinoma","volume":"452","author":"Sun","year":"2018","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.ejps.2023.106571_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-05553-0","article-title":"Anti-tumor activity and immunotherapeutic potential of a bisphosphonate prodrug","volume":"7","author":"Tanaka","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ejps.2023.106571_bib0054","doi-asserted-by":"crossref","DOI":"10.1111\/cas.13491","article-title":"Expansion of human \u03b3\u03b4 T cells for adoptive immunotherapy using a bisphosphonate prodrug","volume":"109","author":"Tanaka","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.ejps.2023.106571_bib0001","article-title":"Open source software for semi-automated histomorphometry of bone resorption and formation parameters","volume":"99","author":"van \u2019t Hof","year":"2017","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.ejps.2023.106571_bib0055","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201801791RR","article-title":"Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw","volume":"33","author":"Zhu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ejps.2023.106571_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2016.02.016","article-title":"Uptake of free, calcium-bound and liposomal encapsulated nitrogen containing bisphosphonates by breast cancer cells","volume":"86","author":"Zlatev","year":"2016","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098723002014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:08:31Z","timestamp":1760530111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098723002014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":56,"alternative-id":["S0928098723002014"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106571","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposome-encapsulated zoledronate increases inflammatory macrophage population in TNBC tumours","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2023.106571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106571"}}